iRadimed
IRMD
162 hedge funds and large institutions have $422M invested in iRadimed in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 63 increasing their positions, 53 reducing their positions, and 20 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 53
15% more capital invested
Capital invested by funds: $365M → $422M (+$56.3M)
0.73% more ownership
Funds ownership: 54.73% → 55.46% (+0.73%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 168 → 162 (-6)
30% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 20
86% less call options, than puts
Call options by funds: $36K | Put options by funds: $251K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.27M |
| 2 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
+$1.73M |
| 3 |
SG Americas Securities
New York
|
+$1.61M |
| 4 |
JIC
Johnson Investment Counsel
Cincinnati,
Ohio
|
+$1.41M |
| 5 |
Polen Capital Management
Boca Raton,
Florida
|
+$1.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Copeland Capital Management
Conshohocken,
Pennsylvania
|
-$1.79M |
| 2 |
Goldman Sachs
New York
|
-$1.41M |
| 3 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$1.23M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$1.06M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$884K |
IRMD Hedge Fund Activity: Q2 2025 in Review
162 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2025, worth a combined $422M — up 15% from $365M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of IRMD and 14 opened new positions — a net loss of 6 holders — while 53 trimmed existing stakes and 63 added.
The largest buyer was Millennium Management, adding an estimated $2.27M. The largest seller was Copeland Capital Management, cutting an estimated $1.79M.
- 162 institutional investors held iRadimed (IRMD) as of Q2 2025, down from 168 in Q1 2025.
- Funds reported $422M of iRadimed stock for Q2 2025, up 15% quarter-over-quarter.
- 14 funds opened new iRadimed positions in Q2 2025 and 20 closed out, a net change of -6 holders.
- The largest iRadimed buyer in Q2 2025 was Millennium Management, an estimated $2.27M added.
- The largest iRadimed seller in Q2 2025 was Copeland Capital Management, an estimated $1.79M sold.
Based on aggregated 13F filings for Q2 2025.